InDevR recently appointed Amy Whittier as its director of sales and marketing and Michael Minard as its director of business development. Boulder, Colo. – InDevR recently appointed Amy Whittier as its director of sales and marketing and Michael Minard as its director of business development. “Amy’s international marketing experience in the medical device and diagnostic […]
Partnership to address increasing demand for protein biomarker testing in pharmaceutical research and development in the Chinese market BEIJING, China. – Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership […]
Penzberg, Germany – Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that Newcastle-based genomic services provider NewGene Ltd. has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Sequence Capture Arrays with sequencing on the Genome Sequencer FLX System from 454 Life Sciences, a Roche Company. NewGene […]
Billerica, Mass. – Aushon BioSystems, Inc., a leading provider of advanced microarray products and laboratory services for biomarker discovery, development and analysis, announces that Sven Beushausen, Ph.D., has been appointed to the position of Chief Scientific Officer. Dr. Beushausen brings more than a quarter century of scientific research and product development experience to this new […]
TOKYO – Toray Industries, Inc. (TOKYO:3402) announces a competition award for groundbreaking research that uses DNA microarray analysis. The award is open for every researcher, an important part of whose study plans, consist of gene expression analyses. The winners, who hope to collaborate and develop the analysis with their research plan, get the 3D-Gene™ award. […]
Oxford, UK – Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, and Biotype Diagnostics GmbH are pleased to announce the completion of a licence agreement granting Biotype access to OGT patents for the detection of DNA sequence variations. The licence, which will remain valid for the lifetime […]
Madison, USA and Penzberg, Germany — Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) today announced that one of New Zealand’s largest medical laboratories has adopted the NimbleGen CGX Cytogenetics Microarray Solution. Canterbury Health Laboratories has implemented the NimbleGen workflow solution for Cytogenetics including arrays, reagents, instruments, and software at their core facility in Christchurch, New […]
Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray […]
BioDiscovery, Inc. a leader in integrated software solutions for genomics data analysis from high-throughput microarray and Next-Gen sequencing technologies, announced today the release of version 5.1 of its popular Nexus Copy Number software, the leading platform independent and user friendly application for DNA copy number analysis. El Segundo, CA – BioDiscovery, Inc. a leader in […]
Sunnyvale, CA – SciGene, a developer of instruments that automate the sample processing workflow used for microarray based tests, announced today that it has been awarded a grant in excess of $240,000 under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance development of an automated genetic analysis system for a variety of human diseases. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
